Pfizer Inc (PFIZ34) — Free Cash Flow Generation Index
Pfizer Inc (PFIZ34) has a Free Cash Flow Generation Index of 0.36x as of June 2026. Free cash flow of R$302.00 Million represents 0% of operating cash flow (R$835.00 Million). Explore capital reinvestment ratio of Pfizer Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Pfizer Inc Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Pfizer Inc across 12 annual periods. For the full cash flow conversion analysis, see how efficiently does Pfizer Inc generate cash.
Annual Free Cash Flow Generation for Pfizer Inc (2014–2025)
Year-by-year Free Cash Flow Generation Index for Pfizer Inc. Check cash flow reinvestment rate of Pfizer Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (BRL) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | R$9.07 Billion | R$11.71 Billion | R$2.63 Billion | ▲ +0.5% |
| 2024 | 0.77x | R$9.84 Billion | R$12.74 Billion | R$2.91 Billion | ▲ +13.6% |
| 2023 | 0.68x | R$8.18 Billion | R$12.04 Billion | R$3.86 Billion | ▼ -23.6% |
| 2022 | 0.89x | R$26.03 Billion | R$29.27 Billion | R$3.24 Billion | ▼ -3.0% |
| 2021 | 0.92x | R$29.87 Billion | R$32.58 Billion | R$2.71 Billion | ▲ +13.7% |
| 2020 | 0.81x | R$11.61 Billion | R$14.40 Billion | R$2.79 Billion | ▲ +1.5% |
| 2019 | 0.79x | R$9.99 Billion | R$12.59 Billion | R$2.59 Billion | ▼ -7.8% |
| 2018 | 0.86x | R$13.63 Billion | R$15.83 Billion | R$2.20 Billion | ▲ +1.5% |
| 2017 | 0.85x | R$14.25 Billion | R$16.80 Billion | R$2.22 Billion | ▼ -24.5% |
| 2016 | 1.12x | R$18.19 Billion | R$16.19 Billion | R$2.00 Billion | ▲ +2.6% |
| 2015 | 1.10x | R$16.09 Billion | R$14.69 Billion | R$1.40 Billion | ▲ +2.3% |
| 2014 | 1.07x | R$18.28 Billion | R$17.08 Billion | R$1.20 Billion | — |